This purposeful conversation between the serotoninergic and central dopaminergic methods continues to be demonstrated in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic effects of psilocybin [5].It’s remained unlawful ever given that, but thanks to the effort and hard work of activists and researchers’